Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
Tomáš Hrnčíř, Tomáš Hrnčíř, Miloslav Kverka, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 957-957
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Tomáš Hrnčíř
Microorganisms (2022) Vol. 10, Iss. 3, pp. 578-578
Open Access | Times Cited: 166
The Influence of Gut Microbiota on Oxidative Stress and the Immune System
C Kunst, Stephan Schmid, M Michalski, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1388-1388
Open Access | Times Cited: 69
Microbiota revolution: How gut microbes regulate our lives
Marica Colella, Ioannis Alexandros Charitos, Andrea Ballini, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 28, pp. 4368-4383
Open Access | Times Cited: 64
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1849-1849
Open Access | Times Cited: 39
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 20
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 45
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients
Francesco Maria Calabrese, Vittoria Disciglio, Isabella Franco, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1773-1773
Open Access | Times Cited: 41
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28
Bacteroides and NAFLD: pathophysiology and therapy
Jun Zhang, Jing Zhou, Zheyun He, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression
J. Jaeger, Annette Brandt, Wenfang Gui, et al.
JHEP Reports (2024) Vol. 6, Iss. 3, pp. 100987-100987
Open Access | Times Cited: 8
Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis
Ting Wang, Taichi Ishikawa, Minoru Sasaki, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
Yuanshe Huang, Xiaodong Wang, Lai Zhang, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 32
Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth
Todd Testerman, Zhongyao Li, Brittany Galuppo, et al.
Hepatology Communications (2022) Vol. 6, Iss. 8, pp. 1962-1974
Open Access | Times Cited: 27
Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
Shuyu Liu, Xilan Yang
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 20
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis
Ana María Gómez Pérez, P. Ruiz‐Limón, Jordi Salas‐Salvadó, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
The Gut Microbiome Responds Progressively to Fat and/or Sugar-Rich Diets and Is Differentially Modified by Dietary Fat and Sugar
João Pessoa, Getachew D. Belew, Cristina Barroso, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2097-2097
Open Access | Times Cited: 17
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis
Ehsan Amini‐Salehi, Soheil Hassanipour, Mohammad-Hossein Keivanlou, et al.
Nutrition Reviews (2023) Vol. 82, Iss. 6, pp. 815-830
Closed Access | Times Cited: 17
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 6
MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options
Yuming Shi, Erfan Taherifard, A.I. Saeed, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5965-5983
Open Access | Times Cited: 6
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Archives of Microbiology (2024) Vol. 206, Iss. 2
Open Access | Times Cited: 5
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
Tianqi Cai, Xinhua Song, Xiaoxue Xu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Ginsenoside Rg5 Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet
Yingying Shi, Jianbo Chen, Di Qu, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 842-842
Open Access | Times Cited: 5
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4857-4857
Open Access | Times Cited: 5
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 217-217
Open Access
Page 1 - Next Page

Scroll to top